The inability to recover intracellular ATP levels after a stress in obesity may explain the predisposition to liver injury in the obese caused by ischemia-reperfusion, for example donor liver ...

NAFLD is a chronic liver disease caused by fat buildup in the liver, even with little to no alcohol use. Risk factors for NAFLD include being overweight or obese, having type 2 diabetes, high ...

Fatty liver disease, including non‑alcoholic fatty liver disease (NAFLD) or metabolic dysfunction‑associated steatotic liver disease (MASLD), occurs when fat accumulates in liver cells, often without ...

With the rising epidemic of obesity, metabolic syndrome, and type 2 diabetes mellitus in China, metabolic dysfunction-associated non-alcoholic fatty liver disease has become the most prevalent chronic ...

MASH is the new term for NASH. MASH stands for metabolic dysfunction–associated steatohepatitis, a type of liver disease. The liver disease used to be referred to as non-alcoholic steatohepatitis, or ...

Several comorbidities are associated with nonalcoholic fatty liver disease, including cardiovascular disease, type 2 diabetes, and sleep apnea. Comorbidities refer to having two or more coexisting ...

Nonalcoholic fatty liver disease (NAFLD) can be reversed with several lifestyle changes, including diet and physical activity. NAFLD is a condition where fat builds up around the liver and is common ...

Non-alcoholic fatty liver disease (NAFLD) stands as a prominent liver disorder globally, with its incidence surging from 25.26% in 1990–2006 to 38.00% in 2016–2019. NAFLD characterizes the ...